FDA inspection
Janssen Pharmaceuticals, Inc.: FDA inspection ending Jan 21, 2000
FDA inspection 11003 · Titusville, NJ
Key facts
| Inspection ID | 11003 |
|---|---|
| Firm | Janssen Pharmaceuticals, Inc. |
| FEI number | 2242843 |
| Address | 1125 Trenton Harbourton Rd |
| City | Titusville |
| State | NJ |
| ZIP | 08560-1504 |
| Fiscal year | 2000 |
| Inspection end date | Jan 21, 2000 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data